Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Quarterly results Appointed director Acq. announced Inv. presentation
|
Microbot Medical Inc. (MBOT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/27/2023 |
8-K
| Quarterly results |
08/15/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/10/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
08/03/2023 |
4
| Gadot Harel (Chairman, President and CEO) has filed a Form 4 on Microbot Medical Inc.
Txns:
| Granted 80,000 options to buy
@ $2.43, valued at
$194.4k
|
|
08/03/2023 |
4
| Sharon Simon (General Manager, CTO) has filed a Form 4 on Microbot Medical Inc.
Txns:
| Granted 17,500 options to buy
@ $2.43, valued at
$42.5k
|
|
08/03/2023 |
4
| Morag Eyal (Chief Medical Officer) has filed a Form 4 on Microbot Medical Inc.
Txns:
| Granted 17,500 options to buy
@ $2.43, valued at
$42.5k
|
|
08/03/2023 |
4
| Vaknin Rachel (CFO) has filed a Form 4 on Microbot Medical Inc.
Txns:
| Granted 17,500 options to buy
@ $2.43, valued at
$42.5k
|
|
07/25/2023 |
8-K
| Quarterly results |
07/18/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
07/18/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
07/14/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
07/11/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
07/11/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
06/29/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
06/16/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
06/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs:
|
"SERIES C PREFERRED INVESTMENT OPTION Microbot Medical Inc. Preferred Investment Option Shares: ______ Issue Date: June ___, 2023 Initial Exercise Date: June ___, 2023 THIS SERIES C PREFERRED INVESTMENT OPTION certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on December ___, 2028 1 but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitio...",
"PLACEMENT AGENT PREFERRED INVESTMENT OPTION Microbot Medical Inc. Preferred Investment Option Shares: ______ Initial Exercise Date: June 6, 2023 THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on June 2, 2028 but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2. This Preferred Investment Option is being is...",
"25 Recreation Park Drive, Unit 108",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of June 2, 2023, between Microbot Medical Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act as to the Shares and the Pre-Funded Warrants and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D thereunder as to the Preferred Investment Options, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agre...",
"Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The- Market under Nasdaq Rules",
"Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules" |
|
06/05/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
06/02/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/31/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/25/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs:
|
"PRE-FUNDED COMMON STOCK PURCHASE WARRANT Microbot Medical Inc. Warrant Shares: Initial Exercise Date: May 24, 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that...",
"PLACEMENT AGENT PREFERRED INVESTMENT OPTION Microbot Medical Inc. Preferred Investment Option Shares: ______ Initial Exercise Date: November 24, 2023 THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on November 24, 2026 but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2. This Preferred Investment Option i...",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of May 23, 2023, between Microbot Medical Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agr...",
"Holder of Preferred Investment Options to Purchase Common Stock",
"Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules",
"Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules" |
|
05/24/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
05/23/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs:
|
"PLACEMENT AGENT PREFERRED INVESTMENT OPTION Microbot Medical Inc. Preferred Investment Option Shares: ______ Initial Exercise Date: November 23, 2023 THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on November 23, 2026 but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2. This Preferred Investment Option i...",
"25 Recreation Park Drive, Unit 108",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of May 22, 2023, between Microbot Medical Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agr...",
"Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules",
"Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules" |
|
05/23/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
05/18/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
05/17/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/16/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
05/08/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
05/05/2023 |
8-K
| Quarterly results |
05/03/2023 |
8-K
| Quarterly results |
03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
03/16/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
|
|
|